William S. Richmond

Life Sciences

• Bain Capital in its investment, alongside existing lead investor Kohlberg, in PCI Pharma Services, a contract development and manufacturing organization (CDMO) focused on biotherapies
• Waters Corporation (NYSE: WAT) in its pending $39 billion Reverse Morris Trust combination with Becton, Dickinson and Company's (NYSE: BDX) Biosciences & Diagnostics Solutions business to create a life sciences and diagnostics leader
• Eli Lilly and Company (NYSE: LLY) on a definitive agreement to purchase Verve Therapeutics, Inc. (Nasdaq: VERV)
• BayPine in its acquisition of CenExel Clinical Research, a provider of a clinical trial site network
• Olympus Partners in its acquisition of PAI Pharma
• Owens & Minor (NYSE: OMI) in its proposed $1.36 billion acquisition of Rotech Healthcare, a provider of home medical equipment
• Avista Healthcare Partners in its acquisition of Trillium Health Care Products, a contract development and manufacturing organization of branded over-the-counter products, from New Water Capital
• Trilantic North America in its investment in SOFIE Biosciences, a Positron Emission Tomography (PET) radiopharmacy and contract development and manufacturing organization (CDMO)
• Silver Oak backed-Integrated Oncology Network, a provider of oncology services, in its pending $1.115 billion sale to Cardinal Health (NYSE: CAH)
• EQT-led consortium in the £4.5 billion acquisition of Dechra Pharmaceuticals (LSE: DPH), a provider of specialist veterinary pharmaceuticals and related products
• Nordic Capital in its acquisition of IntegriChain, a platform for pharma commercialization and market access, from Accel-KKR
• Bristol Myers Squibb (NYSE: BMY) in its $5.8 billion acquisition of Mirati Therapeutics (NASDAQ: MRTX), a commercial stage research and development biotechnology company
• Owens & Minor (NYSE: OMI) in its $1.6 billion acquisition of Apria (NASDAQ: APR), a provider of integrated home healthcare equipment and related services
• EQT-backed Recipharm in its acquisition of Arranta Bio, an advanced therapy medicinal products (ATMPs) contract development and manufacturing organization (CDMO), from Ampersand Capital Partners
• EQT-backed Recipharm in its acquisition of Vibalogics, a virotherapy contract development and manufacturing organization (CDMO), from Ampersand Capital Partners
• The Jordan Company in its investment in WEP Clinical, a specialist pharma services company that works with drug developers to help patients and physicians gain early access to medicines

Healthcare Providers

• Brookfield in its $185 million strategic investment into Orthopedic Care Partners
• Silver Oak backed-Integrated Oncology Network, a provider of oncology services, in its $1.115 billion sale to Cardinal Health (NYSE: CAH)
• VSP Vision in its acquisition of Eyemart Express from FFL Partners and Leonard Green & Partners
• Cressey & Company in the acquisition of HealthDrive, a provider of clinical services to patients residing in long-term care facilities, from Bain Capital Double Impact
• TPG's The Rise Fund in its investment in Banyan Treatment Centers, a provider of substance use disorder and mental health services
• Vertava Health of Mississippi, a provider of addiction treatment and mental health services, in its sale to Bradford Health Services
• Percheron Capital-backed Animal Dermatology Group in its acquisition of Animal Dermatology and Allergy Specialists
• Seattle Reproductive Medicine, a fertility center, in its sale to Pinnacle Fertility
  

Healthcare Technology

• Summit Partners in their growth investment into RIS Rx
• Bain Capital Tech Opportunities in its investment in the combination of Greenphire, a provider of clinical trial payments, financial management and patient support tools, and Suvoda, a clinical trial technology company
• Trinity Hunt Partners in its investment in TNT Dental, a digital marketing agency
• GTCR, alongside Avryo Health Services, in its investment in 7to7 Dental, a dental service organization
• Trinity Hunt Partners in its investment in Coker, a healthcare advisory firm
• GTCR-backed RevSpring, a provider of communication and payment solutions, in its sale to Frazier Healthcare Partners 
• Olympus Partners in the sale of Soliant, a provider of workforce solutions in K-12 school districts and healthcare facilities, to The Vistria Group
• Stone Point Capital-backed Tivity Health in its acquisition of Burnalong, a digital health, wellness and fitness platform
• EW Healthcare Partners in its acquisition of Enercon Technologies, a provider of electronic product development and manufacturing services
• Vesey Street Capital Partners in its sale of QualityMetric, a provider of tools and technology that measure health from the patient's point of view
• Olympus Partners in its acquisition of EyeSouth Partners, an eye care management services organization, from Shore Capital Partners
• Francisco Partners in its acquisition of the healthcare data and analytics assets from IBM (NYSE: IBM) that are currently part of the Watson Health business
• Thoma Bravo in its $6.9 billion acquisition of SailPoint Technologies (NYSE: SAIL), enterprise identity security provider
• Bain Capital Private Equity in its investment in CitiusTech, a provider of technology and consulting services to healthcare and life sciences companies 

Restructuring

• Invitae Corporation and certain of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey. Invitae is headquartered in San Francisco, California and is a leader in the genetic testing field. Prior to commencing Chapter 11, Invitae secured support to implement a go-forward sale process by signing a transaction support agreement with a significant majority of its secured noteholders
• Eyecare Service Partners in its $563 million recapitalization

Nelson Mullins Riley & Scarborough 

Ernst & Young

Will provides pro bono legal counsel to individuals seeking Special Immigrant Juvenile classification.